Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Medicover AB ( ($SE:MCOV.B) ) has issued an update.
Medicover AB will host an Investor Update in Stockholm on 11 February 2026, where its CEO and CFO will brief investors, analysts and media on the group’s strategy, business performance and key priorities. The English-language event, which will be held both in person and via webcast, underscores the company’s efforts to maintain transparency with capital markets and may provide fresh insight into its operational trajectory and strategic positioning across its core healthcare and diagnostics markets.
The most recent analyst rating on ($SE:MCOV.B) stock is a Hold with a SEK234.00 price target. To see the full list of analyst forecasts on Medicover AB stock, see the SE:MCOV.B Stock Forecast page.
More about Medicover AB
Medicover AB is a leading international healthcare and diagnostic services company, operating a broad network of ambulatory clinics, hospitals, laboratories and blood-drawing points. Founded in 1995, the group focuses on specialty care in key markets including Poland, Germany, Romania and India, generating €2,092 million in revenue in 2024 and employing more than 47,000 people.
Average Trading Volume: 75,652
Technical Sentiment Signal: Hold
Current Market Cap: SEK31.42B
For detailed information about MCOV.B stock, go to TipRanks’ Stock Analysis page.